Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From ronran (Subject: Your request re Acer's motion)

< interestingly, Acer states that it has not been presented with any agreements between TPL and Moore (presumably thus including the Master Agreement). Acer also asserts that TPL has not demonstrated a “common interest” as defined in the law that would provide a privilege or similar protection for the documents. TPL, of course, asserts the contrary.>

Even more interesting ---

If TPL/PTSC desires the two documents to be declared privileged (assuming they are somehow damaging to the case or 336 patent), all TPL has to do is state Moore is a co-owner of the MMP. Of course, that position opens pandora's box in the separate litigation between Moore and TPL/Leckrone. I do believe TPL is claiming full ownership of the other 50% not owned by PTSC. Corrections welcomed.

Opty

Share
New Message
Please login to post a reply